Liver Transplant Failure
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Liver Graft Viability Assessment During Normothermic Regional Perfusion
Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
Plasmatic Factor V as a Predictor of Graft Dysfunction After Liver Transplantation
Retrograde Reperfusion Versus Antegrade Liver Transplant Reperfusion
Mortality, Morbidity and Risk Factors of Liver Retransplantation
Early Allograft Failure Simplified Estimation (EASE) in Liver Transplantation
Antibodies and Liver Retransplantation